FDA approves first once-weekly drug treatment regimen for hemophilia
Oct. 11 (UPI) — Patients suffering from hemophilia received a “meaningful” advancement on Friday when federal regulators approved the first once-weekly treatment for the disease. Hympavzi, made by Pfizer, is … Click to Continue »
View original article
Contributor:
